198205-80-0 Usage
Uses
Used in Pharmaceutical Industry:
(2'-TRIFLUOROMETHYLBIPHENYL-4-YL)-METHANOL serves as a building block for the synthesis of various bioactive molecules, playing a crucial role in the development of new pharmaceutical compounds.
Used in Agrochemical Industry:
Similarly, in the agrochemical field, this compound is utilized as a starting material for synthesizing bioactive molecules that can be used in the development of pesticides, herbicides, and other agricultural chemicals.
Used in Material Science:
(2'-TRIFLUOROMETHYLBIPHENYL-4-YL)-METHANOL is also employed in the development of materials for applications such as liquid crystals and organic light-emitting diodes, where its unique properties are harnessed to improve the performance of these advanced technologies.
Check Digit Verification of cas no
The CAS Registry Mumber 198205-80-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,8,2,0 and 5 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 198205-80:
(8*1)+(7*9)+(6*8)+(5*2)+(4*0)+(3*5)+(2*8)+(1*0)=160
160 % 10 = 0
So 198205-80-0 is a valid CAS Registry Number.
198205-80-0Relevant articles and documents
S1P RECEPTORS MODULATORS
-
Page/Page column 100, (2010/04/30)
The invention relates to novel compounds that have S1P receptor modulating activity and, preferably, apoptotic activity and/or anti proliferative activity against cancer cells and other cell types. Further, the invention relates to a pharmaceutical comprising at least one compound of the invention for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression, for example, cancer. A further aspect of the invention relates to the use of a pharmaceutical comprising at least one compound of the invention for the manufacture of a medicament for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression such as cancer.